Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency: A randomized double-blind trial

International Immunopharmacology

Volumn 3, Issue 9, 2003, Pages 1325-1333

  Roifman, Chaim M ^a   Schroeder, Harry ^b   Berger, Melvin ^c   Sorensen, Ricardo ^d   Ballow, Mark ^e   Buckley, Rebecca H ^f   Gewurz, Anita ^g   Korenblat, Phillip ^h   Sussman, Gordon ⁱ   Lemm, Georg ^j   Stein, Mark ^k   Stark, Donald ^s   Ermitano, Maria Louisa ^d   Desroches, Anne ^l   Mazer, Bruce ^s   Church, Joseph ^s   Ballas, Zuhair ^m   Filipovich, Alexandra ⁿ   Friday, Gilbert ^s   Graffino, Donatella ^o   Haysman, Melvin ^s   Knutsen, Alan ^p   Richmond, Wendel ^s   Rubinstein, Arye ^q   Marquinez, Frederick ^s   McNeil, Don ^s   Skoda Smith, Susanne ^r   more..

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e CHILDREN S HOSPITAL OF BUFFALO   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h Clinical Research Center   (United States)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j BAYER CORPORATION   (United States)

^k Allerg Assoc of the Palm Beaches   (United States)

^l UNIVERSITY OF MONTREAL   (Canada)

^m UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

ⁿ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^o Asthma Allerg/Sinus Ctr of NJ   (United States)

^p SAINT LOUIS UNIVERSITY   (United States)

^q ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^r UNIVERSITY OF FLORIDA   (United States)

^s NONE

more..

Author keywords

IgG; IGIV; Immunoglobulin; Immunotherapy; IVIG; Primary immunodeficiency; Sinopulmonary infection; Sinusitis; Viral safety

Indexed keywords

HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; OCTANOIC ACID;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BIOSAFETY; BRONCHIECTASIS; BRONCHITIS; CHILD; CHILL; CHROMATOGRAPHY; CHRONIC DISEASE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG INFUSION; DRUG SAFETY; DRUG TOXICITY; DYSPNEA; FACE EDEMA; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HEALTH CENTER; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INFECTION PREVENTION; INFECTION RATE; INJURY; LUNG FUNCTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE RIGIDITY; NAUSEA; NECK; OTITIS MEDIA; PARALLEL DESIGN; PERIPHERAL EDEMA; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SINUSITIS; STATISTICAL ANALYSIS; SUBSTITUTION THERAPY; THORAX PAIN; URTICARIA; VALIDATION PROCESS; VERTIGO; VIRUS INFECTION; VIRUS TRANSMISSION; VOMITING;

EID: 10744229712     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00134-6     Document Type: Article

References (18)

1. Buckley R.H., Schiff R.I. The use of intravenous immune globulin in immunodeficiency diseases. N. Engl. J. Med. 325(2):1991;110-117.
2. Korneyeva M., Hotta J., Lebing W., Rosenthal R.S., Franks L., Petteway S.R. Jr. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates. Biologicals. 30(2):2002;153-162.
3. Lebing W., Remington K., Schreiner C., Paul H.-I. Properties of a new intravenous immunoglobulin (IVIG-C, 10%) produced by caprylate virus inactivation and column chromatography. Vox Sang. 84:2003;193-201.
4. Trejo S.R., Hotta J., Lebing W., Stenland C., Evans Storms R.et al. Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process. Vox Sang. 84:2003;176-187.
5. Primary immunodeficiency diseases. Report of a WHO scientific group. Clin. Exp. Immunol. 109(Suppl. 1):1997;1-28.
6. Human normal immunoglobulin for intravenous administration. European pharmacopoeia. 3rd ed. 1997;963-965 Council of Europe, Strasbourg.
7. Ballow M., Berger M., Bonilla F.A., Buckley R., Cunningham-Rundles C.H.et al. Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex™, 10%). Vox Sang. 84:2003;202-210.
8. Rodary C., Com-Nougue C., Tournade M.F. How to establish equivalence between treatments: a one-sided clinical trial in paediatric oncology. Stat. Med. 8(5):1989;593-598.
9. Ammann A.J., Ashman R.F., Buckley R.H., Hardie W.R., Krantmann H.J.et al. Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. Clin. Immunol. Immunopathol. 22(1):1982;60-67.
10. Stiehm E.R., Ashida E., Kim K.S., Winston D.J., Haas A., Gale R.P. Intravenous immunoglobulins as therapeutic agents. Ann. Intern. Med. 107(3):1987;367-382.
11. Gwaltney J.M. Jr., Phillips C.D., Miller R.D., Riker D.K. Computed tomographic study of the common cold. N. Engl. J. Med. 330(1):1994;25-30.
12. Schur PH. IgG subclasses - a review. Ann. Allergy 1987;58(2):89-96, 99.
13. Cunningham-Rundles C., Siegal F.P., Smithwick E.M., Lion-Boule A., Cunningham-Rundles S.et al. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann. Intern. Med. 101(4):1984;435-439.
14. Roifman C.M., Levison H., Gelfand E.W. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet. 1(8541):1987;1075-1077.
15. Roifman C.M. Gs chronic sinopulmonary disease in patients with hypogammaglobulinemia. Pediatr. Infect. Dis. J. 7(5 Suppl.):1988;S92-S96.
16. Gelfand E.W., Reid B., Roifman C.M. Intravenous immune serum globulin replacement in hypogammaglobulinemia. A comparison of high- versus low-dose therapy. Monogr. Allergy. 23:1988;177-186.
17. Eijkhout H.W., van Der Meer J.W., Kallenberg C.G., Weening R.S., van Dissel J.T.et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann. Intern. Med. 135(3):2001;165-174.
18. van der Zee J.S., van Swieten P., Aalberse R.C. Inhibition of complement activation by IgG4 antibodies. Clin. Exp. Immunol. 64(2):1986;415-422.